previous
observ
known
broadli
neutral
antibodi
bnab
highli
diverg
germlin
antibodi
contrast
bnab
hendra
viru
nipah
viru
sar
coronaviru
sar
cov
hypothes
germlin
antibodi
differ
matur
bnab
may
bind
epitop
matur
antibodi
provid
first
evid
support
hypothesi
use
individu
put
germlinelik
predecessor
antibodi
valid
hypothesi
understand
initi
immun
respons
differ
virus
two
phagedisplay
human
cord
bloodderiv
igm
librari
construct
contain
mostli
germlin
antibodi
antibodi
low
level
somat
hypermut
pan
differ
envelop
glycoprotein
env
sar
cov
protein
receptorbind
domain
rbd
solubl
hendra
viru
g
protein
sg
despit
high
sequenc
combinatori
divers
observ
cord
bloodderiv
igm
antibodi
repertoir
enrich
binder
env
observ
contrast
consider
specif
enrich
produc
pan
rbd
sg
one
select
monoclon
antibodi
rbd
high
nm
affin
somat
mutat
result
support
expand
initi
hypothesi
fundament
differ
immun
respons
lead
elicit
bnab
compar
sar
cov
hendra
viru
use
strategi
minim
elimin
strong
bind
germlin
antibodi
env
contrast
sar
cov
hendra
viru
perhap
virus
caus
acut
infect
bind
germlin
antibodi
minim
somat
mutat
antibodi
rel
high
affin
could
one
reason
success
sg
rbd
vaccin
immunogen
elicit
potent
broadli
neutral
antibodi
bnab
immun
remain
challeng
previous
hypothes
may
use
conserv
structur
initi
immun
respons
exist
hole
human
germlin
b
cell
receptor
bcr
repertoir
ie
lack
germlin
antibodi
capabl
bind
structur
support
hypothesi
show
germlinelik
antibodi
correspond
close
known
bnab
lack
measur
bind
envelop
glycoprotein
env
observ
led
investig
matur
pathway
two
bnab
whose
structur
function
well
known
well
identif
character
sever
human
igmderiv
monoclon
antibodi
mab
select
larg
phagedisplay
human
antibodi
librari
construct
healthi
donor
studi
demonstr
germlin
intermedi
correspond
also
fail
bind
env
high
affin
wherea
put
germlinelik
predecessor
antibodi
igmderiv
mab
diverg
less
correspond
germlin
high
bind
affin
env
howev
latter
enhanc
potent
neutral
infect
primari
isol
studi
b
cell
lineag
matur
pathway
bnab
may
sidestep
impedi
vaccin
develop
part
studi
human
antibodyom
toward
understand
initi
respons
immunogen
previous
gener
larg
igm
antibodi
librari
develop
character
igm
mab
sar
coronaviru
sar
cov
protein
receptorbind
domain
rbd
solubl
hendra
viru
g
protein
sg
human
umbil
cord
blood
b
lymphocyt
presum
expos
exogen
antigen
use
sourc
naturallyoccur
germlin
minimallymut
preimmun
antibodi
reason
cord
bloodderiv
igm
librari
might
serv
relev
sourc
select
closest
germlin
antibodi
correspond
broadli
neutral
mab
exhibit
bind
target
antigen
current
studi
address
hypothesi
human
cord
blood
contain
highaffin
binder
although
highaffin
antibodi
human
infecti
agent
sar
cov
henipavirus
explor
divers
specif
cord
bloodderiv
igm
antibodi
antibodi
librari
character
use
largescal
sanger
sequenc
assess
potenti
repertoir
divers
antibodi
capabl
bind
env
rbd
sg
could
identifi
although
largescal
sequenc
cordblood
deriv
igm
antibodi
repertoir
reveal
rel
high
divers
enrich
observ
sequenti
pan
env
howev
consider
specif
enrich
seen
librari
pan
rbd
antibodi
produc
close
put
germlin
predecessor
result
suggest
could
evolv
elud
strong
bind
minim
somaticallydiversifi
human
antibodi
escap
mechan
adapt
immun
respons
cord
blood
receiv
nation
diseas
research
interchang
ndri
philadelphia
pa
care
taken
contamin
cord
blood
sampl
matern
blood
sar
cov
rbd
human
produc
laboratori
env
bal
provid
fout
institut
human
virolog
baltimor
current
profectu
baltimor
md
solubl
hendra
viru
envelop
glycoprotein
g
sg
jrfl
provid
c
broder
uniform
servic
univers
health
scienc
bethesda
md
con
provid
b
hayn
h
liao
duke
univers
durham
nc
horseradish
peroxidas
hrp
conjug
mous
antibodi
purchas
sigmaaldrich
st
loui
mo
sourc
amplif
antibodi
gene
fragment
cdna
prepar
cord
blood
two
babi
librari
construct
use
phagemid
previous
describ
heavi
vh
light
vl
chain
variabl
domain
antibodi
sequenc
use
standard
sanger
sequenc
method
result
sequenc
sort
trim
produc
independ
pool
heavi
light
chain
sequenc
latter
sort
kappa
v
lambda
v
light
chain
search
translat
sequenc
set
mutuallyexclus
motif
sequenc
analyz
use
program
joinsolv
found
result
product
rearrang
like
yield
function
product
form
data
set
analysi
use
output
joinsolv
germlin
divers
heavi
chain
complementar
determin
region
vh
length
number
mutat
compar
closest
germlin
match
v
j
famili
obtain
sequenc
translat
heavi
light
chain
variabl
segment
librari
sequenc
align
use
trim
equival
length
within
group
v
h
codon
v
codon
v
codon
function
v
h
v
v
translat
germlin
sequenc
ncbi
igblast
databas
http
wwwncbinlmnihgovprojectsigblast
similarli
treat
separ
ident
matric
stream
gener
use
bioedit
number
amino
acid
aa
chang
queri
sequenc
closest
germlin
match
found
joinsolv
determin
combin
cord
blood
librari
use
select
antibodi
antigen
conjug
magnet
bead
dynabead
epoxi
dynal
inc
new
hyde
park
ny
describ
previous
antigen
present
amount
first
second
third
fourth
round
pan
respect
specif
enrich
determin
use
polyclon
phagebas
elisa
ppelisa
briefli
ppelisa
perform
use
corn
highbind
plate
coat
antigen
block
nonfat
dri
milk
pb
mpb
micropl
well
inocul
per
well
mpb
contain
pfu
pool
phage
purifi
round
pan
hour
room
temperatur
follow
wash
pb
contain
tween
pbst
bound
phage
detect
ad
dilut
hrpconjug
mous
antibodi
sigma
st
loui
mo
well
follow
incub
hour
room
temperatur
plate
wash
time
pbst
assay
develop
abst
substrat
roch
indianapoli
absorb
monitor
nm
clone
specif
bound
antigen
identifi
fourth
round
use
monoclon
phage
elisa
mpelisa
describ
solubl
antigenbind
fragment
fab
antibodi
express
purifi
bind
activ
measur
previous
describ
two
rel
larg
member
phagedisplay
human
igm
fab
librari
design
respect
construct
ml
cord
blood
two
babi
describ
materi
method
estim
sequenc
divers
librari
clone
randomli
select
respect
sequenc
ident
sequenc
heavi
light
chain
found
clone
show
product
v
j
rearrang
clone
v
light
chain
famili
v
light
chain
famili
heavi
chain
also
wide
distribut
famili
similar
gene
usag
famili
distribut
observ
result
indic
cord
blood
librari
could
high
level
sequenc
divers
contain
antibodi
gene
fragment
famili
heavi
light
chain
accur
estim
divers
cord
blood
librari
addit
clone
sequenc
product
fulllength
rearrang
vh
vl
sequenc
librari
identifi
similar
sequenc
vh
vl
repertoir
calcul
v
h
sequenc
respect
found
uniqu
tabl
divers
vl
significantli
lower
vh
v
v
vl
domain
v
vl
domain
identifi
uniqu
sequenc
librari
combin
sequenc
v
h
v
v
respect
uniqu
combin
cord
blood
antibodi
repertoir
analyz
gene
usag
vh
length
somat
mutat
compar
closest
germlin
counterpart
heavi
chain
v
hv
region
found
deriv
hv
germlin
famili
fig
contain
repres
subfamili
found
imgt
databas
heavi
chain
hd
j
hj
gene
famili
found
differ
proport
fig
c
length
vh
rang
amino
acid
residu
mode
vh
length
fig
v
v
region
kv
identifi
gene
famili
absent
fig
j
region
kj
distribut
among
five
gene
famili
fig
v
v
region
lv
present
except
three
lv
gene
famili
fig
j
region
lj
mostli
distribut
gene
famili
absent
fig
determin
level
somat
mutat
antibodi
sequenc
combin
cord
blood
repertoir
compar
closest
germlin
number
amino
acid
aa
mutat
calcul
hv
germlin
sequenc
sequenc
contain
one
aa
mutat
remain
two
aa
mutat
sequenc
mutat
found
fig
contrast
light
chain
significantli
less
mutat
lv
respect
give
translat
ident
germlin
number
mutat
occur
j
region
heavi
light
chain
also
calcul
similarli
observ
variabl
region
rel
mutat
observ
hj
lj
fig
mutat
region
estim
difficulti
determin
gene
germlin
mani
antibodi
due
event
recombin
involv
insert
delet
result
suggest
sequenc
divers
librari
like
high
although
light
chain
appear
less
divers
heavi
chain
librari
exhibit
low
level
somat
hypermut
previous
note
known
bnab
highli
diverg
germlin
sequenc
contrast
bnab
sar
cov
henipavirus
less
diversifi
possess
limit
number
mutat
addit
found
germlinelik
predecessor
sever
bnab
lack
measur
bind
env
base
find
hypothes
scarciti
absenc
high
affin
binder
env
minim
somaticallyhypermut
human
cord
blood
antibodi
repertoir
wherea
high
affin
antibodi
human
infecti
agent
includ
sar
cov
henipavirus
easili
found
test
hypothesi
combin
cord
blood
librari
pan
con
synthet
env
design
align
consensu
env
sequenc
group
hendra
viru
protein
sg
parallel
four
round
pan
enrich
bind
specif
pool
phage
determin
ppelisa
interestingli
signific
specif
enrich
observ
select
sg
fig
separ
experi
mix
librari
pan
anoth
env
bal
simultan
rbd
line
previou
observ
mark
enrich
achiev
pan
bal
consider
specif
enrich
seen
librari
pan
rbd
fig
result
support
hypothesi
suggest
env
could
evolv
strategi
avoid
bind
germlin
repertoir
present
epitop
unsuit
minim
somaticallydiversifi
human
antibodi
bind
therebi
deni
chanc
bind
high
affin
strategi
may
repres
way
exploit
viru
escap
strong
immun
respons
determin
extent
antibodi
sar
cov
select
cord
blood
librari
mutat
number
individu
clone
high
affin
sar
cov
rbd
identifi
mpelisa
describ
materi
method
sequenc
clone
reveal
ident
uniqu
clone
design
contain
gene
product
heavi
light
chain
v
region
respect
fig
aa
mutat
v
region
heavi
light
chain
mutat
j
region
purifi
solubl
fab
bound
sar
cov
rbd
ec
nm
bind
irrelev
antigen
bal
observ
suggest
specif
bind
fig
previous
vesicular
stomat
viru
vsv
specif
antibodi
v
h
gene
combin
elicit
mous
model
found
devoid
somat
mutat
show
high
bind
avid
result
line
previou
find
provid
support
evid
hypothesi
extens
somat
hypermut
could
uniqu
featur
bnab
perhap
virus
caus
chronic
infect
summari
pan
larg
phagedisplay
minim
somaticallydiversifi
antibodi
librari
deriv
human
cord
blood
env
yield
signific
binder
howev
consider
specif
enrich
seen
pan
sar
cov
rbd
hendra
viru
sg
yield
antibodi
rbd
whose
sequenc
close
parent
germlin
use
whole
env
studi
one
would
expect
bind
activ
due
highli
immunogen
epitop
loop
actual
could
bind
initi
immun
respons
though
may
capabl
divert
immun
respons
conserv
epitop
therefor
fact
rel
high
affin
bind
env
might
indic
immun
respons
may
fast
gener
differ
case
virus
result
provid
evid
support
expand
hypothesi
use
strategi
base
absent
weak
bind
conserv
epitop
germlin
antibodi
escap
neutral
immun
respons
character
human
cord
blood
igm
antibodi
librari
largescal
sequenc
phage
fab
librari
human
cord
blood
yield
binder
hiv
studi
explain
differenti
immun
respons
hiv
virus
number
uniqu
duplic
sequenc
obtain
cord
blood
igm
librari
use
sanger
sequenc
method
